Swiss legislation permits a restricted medical application of our products, subject to individual authorisation issued by the Swiss federal Office of Public Health (BAG/FOPH) with a prescription. This exemption permit will no longer be necessary when the new law comes into force from around mid-2022.
The legal requirements differ widely and are currently in transition in many countries. An increasing number of countries in Europe and elsewhere are permitting the medical use of cannabis or cannabis-based preparations.
Currently the export of cannabis or cannabis preparations from Switzerland is not possible due to a restrictive interpretation of Swiss laws by the Swiss federal Office of Public Health. Due to the change in the law, we will be able to export our products from around mid-2022.